Hindustan Times
AsiaPac · 2 hrs ago
Moderna stock jumps 120% after cancer vaccine trial win: What investors need to know
Moderna stock surged after its mRNA cancer vaccine showed positive Phase 3 results with Merck’s Keytruda, boosting hopes for a new melanoma treatment.
Do you trust Hindustan Times?
Sign in to rate
Discussion
?
No comments yet — be the first to start the discussion!